The Sodium Chloride Injection, cataloged under National Stock Number 6505-01-219-8592, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is American Pharmaceutical Partners. Government technical data includes 6 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-219-8592 |
| Primary Part Number | NDC63323-0088-63 |
| Item Name | Sodium Chloride Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | American Pharmaceutical Partners |
| Status | ACTIVE |
| Administration | INTRAVENOUS |
| Primary Container Content Quantity | 200.000 MILLILITERS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | VIAL |
| Active Medicament Medicinal Strength | 234.000 MILLIGRAMS SODIUM CHLORIDE ACTIVE INGREDIENT |
| Total Primary Container Quantity | 20 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| NDC63323-0088-63 PRIMARY | American Pharmaceutical Partners (USA) |
| Reference | Meaning |
|---|---|
| 88B2 | 5/9 Secondary reference Lyphomed Inc Div of Fujisawa Usa Inc |
| NDC00469-8802-00 | 5/9 Secondary reference Lyphomed Inc Div of Fujisawa Usa Inc |
NSN 6505-01-219-8592 is a Sodium Chloride Injection, manufactured by American Pharmaceutical Partners, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-219-8592 has 1 manufacturer part number on file: NDC63323-0088-63 (American Pharmaceutical Partners).
Key specifications for NDC63323-0088-63: Administration: INTRAVENOUS; Primary Container Content Quantity: 200.000 MILLILITERS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: VIAL. 6 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.